CSS LLC’s NRX Pharmaceuticals NRXP Stock Holding History

CSS LLC’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-293	Closed	-$31K	–	740
2019 Q2	$31K	Buy	+293	New	+$30.5K	﹤0.01%	722

Other funds holding NRXP

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

CSS LLC's NRXP Position: Q3 2019 in Review

CSS LLC sold out of NRX Pharmaceuticals (NRXP) in Q3 2019, closing a stake of 293 shares — an estimated $31K sold.

CSS LLC first reported a position in NRXP in Q2 2019 and held it in 1 quarter. The position peaked at $31K in Q2 2019. 15 funds tracked by Wall St. Rank hold NRXP as of Q3 2019.

CSS LLC reported no remaining NRX Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
CSS LLC sold 293 NRX Pharmaceuticals shares in Q3 2019, an estimated $31K.
CSS LLC first reported a position in NRX Pharmaceuticals in Q2 2019 and held it in 1 quarter.
CSS LLC's NRX Pharmaceuticals position peaked at $31K in Q2 2019.
15 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2019.

Based on CSS LLC's 13F filing for Q3 2019, filed 14 Nov 2019.